Healthcare - Biotechnology - NASDAQ - US
$ 9.16
-7.66 %
$ 1.43 B
Market Cap
-8.4
P/E
CASH FLOW STATEMENT
-70.2 M
OPERATING CASH FLOW
-6.09 M
INVESTING CASH FLOW
170 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ocular Therapeutix, Inc.
| Net Income | -80.7 M |
| Depreciation & Amortization | 2.98 M |
| Capital Expenditures | -6.09 M |
| Stock-Based Compensation | 17.8 M |
| Change in Working Capital | -7.41 M |
| Others | -5.7 M |
| Free Cash Flow | -76.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (80.7) | (71.0) | (6.6) | (155.6) | (86.4) | (60.0) | (63.4) | (44.7) | (39.7) | (28.6) | (13.3) | (14.1) |
| Depreciation & Amortization | 3.0 | 2.1 | 2.4 | 2.8 | 2.5 | 2.3 | 1.6 | 0.9 | 0.8 | 0.5 | 0.4 | 0.4 |
| Deferred Income Tax | 0 | 0 | (78.1) | 86.2 | (4.3) | 0 | 9 K | 1.4 | 58 K | 0.3 | 14 K | 49 K |
| Stock Based Compensation | 17.8 | 17.0 | 15.0 | 7.5 | 8.8 | 7.5 | 7.3 | 6.0 | 4.6 | 2.6 | 0.5 | 0.2 |
| Other Operating Activities | (2.9) | (9.0) | 4.6 | 4.4 | 3.7 | 0.4 | 0.4 | 0.4 | 0.2 | 2.5 | 46 K | 86 K |
| Change in Working Capital | (7.4) | 1.3 | (2.9) | 1.2 | (1.9) | 0.6 | 3.5 | 2.1 | 0.5 | 2.2 | (0.2) | 0.7 |
| Cash From Operations | (70.2) | (59.6) | (65.5) | (53.6) | (77.6) | (49.2) | (50.5) | (34.0) | (33.7) | (20.5) | (12.6) | (12.6) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (6.1) | (3.7) | (1.2) | (0.8) | (2.2) | (1.9) | (8.3) | (1.9) | (1.8) | (1.3) | (0.4) | (0.2) |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 35.3 | 37.5 | (36.8) | (37.3) | 0 | 4.0 |
| Cash From Investing Activities | (6.1) | (3.7) | (1.2) | (0.8) | (2.2) | (1.9) | 27.1 | 35.6 | (38.6) | (38.6) | (0.4) | 3.8 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 56.3 | 0 | (0.4) | 0 | 37.3 | 6.4 | 2.4 | 0 | 0.4 | 12.6 | (1.8) | 3.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.4) | 1.5 | 3.3 | 3.3 | 0.5 | 0.7 | 0.4 | 42 K | (0.3) | (3.2) | 8.5 | 23.8 |
| Cash From Financing Activities | 169.8 | 1.5 | 2.9 | 228.0 | 75.3 | 68.6 | 32.0 | 0.6 | 65.7 | 79.0 | 6.7 | 27.3 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 93.5 | (61.9) | (63.9) | 173.6 | (4.5) | 17.5 | 8.6 | 2.2 | (6.6) | 19.9 | (6.3) | 18.5 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (76.3) | (63.3) | (66.7) | (54.4) | (79.8) | (51.1) | (58.7) | (35.9) | (35.5) | (21.8) | (13.0) | (12.8) |